Literature DB >> 27627584

Proteome Analysis of Rheumatoid Arthritis Gut Mucosa.

Tue Bjerg Bennike1, Torkell Ellingsen2,3, Henning Glerup3,4, Ole Kristian Bonderup3,4, Thomas Gelsing Carlsen5, Michael Kruse Meyer5,6, Martin Bøgsted7,8, Gunna Christiansen9, Svend Birkelund5, Vibeke Andersen10,11, Allan Stensballe5.   

Abstract

Rheumatoid arthritis (RA) is an inflammatory joint disease leading to cartilage damage and ultimately impaired joint function. To gain new insight into the systemic immune manifestations of RA, we characterized the colon mucosa proteome from 11 RA-patients and 10 healthy controls. The biopsies were extracted by colonoscopy and analyzed by label-free quantitative proteomics, enabling the quantitation of 5366 proteins. The abundance of dihydrofolate reductase (DHFR) was statistically significantly increased in RA-patient biopsies compared with controls and correlated with the administered dosage of methotrexate (MTX), the most frequently prescribed immunosuppressive drug for RA. Additionally, our data suggest that treatment with Leflunomide, a common alternative to MTX, increases DHFR. The findings were supported by immunohistochemistry with confocal microscopy, which furthermore demonstrated that DHFR was located in the cytosol of the intestinal epithelial and interstitial cells. Finally, we identified 223 citrullinated peptides from 121 proteins. Three of the peptides were unique to RA. The list of citrullinated proteins was enriched in extracellular and membrane proteins and included known targets of anticitrullinated protein antibodies (ACPAs). Our findings support that the colon mucosa could trigger the production of ACPAs, which could contribute to the onset of RA. The MS data have been deposited to ProteomeXchange with identifiers PXD001608 and PXD003082.

Entities:  

Keywords:  ACPA; DHFR; anticitrullinated protein antibody; citrullination; colon mucosa; dihydrofolate reductase; leflunomide; methotrexate; proteomics; rheumatoid arthritis

Mesh:

Substances:

Year:  2016        PMID: 27627584     DOI: 10.1021/acs.jproteome.6b00598

Source DB:  PubMed          Journal:  J Proteome Res        ISSN: 1535-3893            Impact factor:   4.466


  21 in total

Review 1.  The case for periodontitis in the pathogenesis of rheumatoid arthritis.

Authors:  Jan Potempa; Piotr Mydel; Joanna Koziel
Journal:  Nat Rev Rheumatol       Date:  2017-08-24       Impact factor: 20.543

2.  A Cost-Effective High-Throughput Plasma and Serum Proteomics Workflow Enables Mapping of the Molecular Impact of Total Pancreatectomy with Islet Autotransplantation.

Authors:  Tue Bjerg Bennike; Melena D Bellin; Yue Xuan; Allan Stensballe; Frederik Trier Møller; Gregory J Beilman; Ofer Levy; Zobeida Cruz-Monserrate; Vibeke Andersen; Judith Steen; Darwin L Conwell; Hanno Steen
Journal:  J Proteome Res       Date:  2018-04-19       Impact factor: 4.466

Review 3.  Insights into the study and origin of the citrullinome in rheumatoid arthritis.

Authors:  Justyna Fert-Bober; Erika Darrah; Felipe Andrade
Journal:  Immunol Rev       Date:  2019-12-25       Impact factor: 12.988

Review 4.  Interplay of Microbiota and Citrullination in the Immunopathogenesis of Rheumatoid Arthritis.

Authors:  Mohammed A Alghamdi; Elrashdy M Redwan
Journal:  Probiotics Antimicrob Proteins       Date:  2021-05-25       Impact factor: 4.609

5.  Proteomics dataset: The colon mucosa from inflammatory bowel disease patients, gastrointestinal asymptomic rheumatoid arthritis patients, and controls.

Authors:  Tue Bjerg Bennike; Thomas Gelsing Carlsen; Torkell Ellingsen; Ole Kristian Bonderup; Henning Glerup; Martin Bøgsted; Gunna Christiansen; Svend Birkelund; Vibeke Andersen; Allan Stensballe
Journal:  Data Brief       Date:  2017-10-06

Review 6.  Intestinal Dysbiosis and Rheumatoid Arthritis: A Link between Gut Microbiota and the Pathogenesis of Rheumatoid Arthritis.

Authors:  Gabriel Horta-Baas; María Del Socorro Romero-Figueroa; Alvaro José Montiel-Jarquín; María Luisa Pizano-Zárate; Jaime García-Mena; Ninfa Ramírez-Durán
Journal:  J Immunol Res       Date:  2017-08-30       Impact factor: 4.818

7.  Expansion of Rare and Harmful Lineages is Associated with Established Rheumatoid Arthritis.

Authors:  Natalia Mena-Vázquez; Patricia Ruiz-Limón; Isabel Moreno-Indias; Sara Manrique-Arija; Francisco J Tinahones; Antonio Fernández-Nebro
Journal:  J Clin Med       Date:  2020-04-07       Impact factor: 4.241

8.  Identification of new biomarkers to promote personalised treatment of patients with inflammatory rheumatic disease: protocol for an open cohort study.

Authors:  Tina Marie Kringelbach; Bente Glintborg; Estrid V Hogdall; Julia Sidenius Johansen; Merete Lund Hetland
Journal:  BMJ Open       Date:  2018-02-01       Impact factor: 2.692

9.  Identification of brain antigens recognized by autoantibodies in experimental autoimmune encephalomyelitis-induced animals treated with etomoxir or interferon-β.

Authors:  Anne Skøttrup Mørkholt; Kenneth Kastaniegaard; Michael Sloth Trabjerg; Gopana Gopalasingam; Wanda Niganze; Agnete Larsen; Allan Stensballe; Søren Nielsen; John Dirk Nieland
Journal:  Sci Rep       Date:  2018-05-04       Impact factor: 4.379

10.  Intestinal barrier dysfunction plays an integral role in arthritis pathology and can be targeted to ameliorate disease.

Authors:  Diana E Matei; Madhvi Menon; Dagmar G Alber; Andrew M Smith; Bahman Nedjat-Shokouhi; Alessio Fasano; Laura Magill; Amanda Duhlin; Samuel Bitoun; Aude Gleizes; Salima Hacein-Bey-Abina; Jessica J Manson; Elizabeth C Rosser; Nigel Klein; Paul A Blair; Claudia Mauri
Journal:  Med (N Y)       Date:  2021-07-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.